William Walker - 16 Jan 2025 Form 4 Insider Report for KULR Technology Group, Inc. (KULR)

Role: Chief Technology Officer
Signature: /s/ William Walker
Issuer symbol: KULR
Transactions as of: 16 Jan 2025
Transactions value $: $0
Form type: 4
Filing time: 17 Jan 2025, 16:53:17 UTC
Previous filing: 14 Jul 2023
Next filing: 26 Aug 2025
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	KULR	Common Stock	Award	$0	+1,000,000	+200%	$0	1,500,000	16 Jan 2025	Direct	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Effective January 16, 2025, the Board of Directors ("Board") of KULR Technology Group, Inc. (the "Company"), at the recommendation of the Compensation Committee of the Board, approved a restrict stock unit grant ("RSU") to Dr. Walker in the amount of 1,000,000 shares of the Company's common stock. These shares vest in four equal annual installments, with the first annual vest to occur on January 17, 2026, subject to Dr. Walker's continued services to the Company. The beneficial ownership set forth in Column 5 includes the 1,000,000 shares underlying the grant described above and includes the 500,000 shares underlying the RSU grants previously issued to Dr. Walker, even though they are not all expected to settle or vest within 60 days of this Form 4.
F2	The beneficial ownership set forth in Column 5 includes the shares underlying all RSUs held by Dr. Walker, even though they are not all expected to settle or vest within 60 days of this Form 4.

Content

Effective January 16, 2025, the Board of Directors ("Board") of KULR Technology Group, Inc. (the "Company"), at the recommendation of the Compensation Committee of the Board, approved a restrict stock unit grant ("RSU") to Dr. Walker in the amount of 1,000,000 shares of the Company's common stock. These shares vest in four equal annual installments, with the first annual vest to occur on January 17, 2026, subject to Dr. Walker's continued services to the Company. The beneficial ownership set forth in Column 5 includes the 1,000,000 shares underlying the grant described above and includes the 500,000 shares underlying the RSU grants previously issued to Dr. Walker, even though they are not all expected to settle or vest within 60 days of this Form 4.

The beneficial ownership set forth in Column 5 includes the shares underlying all RSUs held by Dr. Walker, even though they are not all expected to settle or vest within 60 days of this Form 4.